COVID-19

Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.

Study shows for most, long-COVID symptoms persist into second year

Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.

News briefs

Real-world evidence shows remdesivir tied to less death in hospitalized COVID patients

COVID-19 fueled increase in hospital-onset MRSA, study finds

Chris Dall

Excess weight in long-COVID patients linked to neurologic symptoms

Quick takes: FDA advisers to weigh COVID vaccines, H5N1 in US cows and poultry

Scientists estimate higher rate of new-onset diabetes after COVID than in general population

Get weekly COVD-19 updates in your inbox.

Newsletter sign-up

Moderna reports promising results for COVID-flu mRNA vaccine

The company said a combo vaccine could streamline immunization for consumers and health providers and make it easier for people to follow public health recommendations.

ECDC, Sweden detail good practices, lessons learned from COVID school-closure policies

The report spells out the complex issues that drove its policies, along with some data gaps officials encountered.

Pandemic procedures slowing heart attack responses

The study is based on heart attack patients seen at Ocean University Medical Center in New Jersey.

FDA greenlights Novavax's updated COVID vaccine

The FDA's announcement paves the way for people to start receiving the vaccine at pharmacies and doctor's offices.

COVID booster uptake hindered by prior infections, fear of side effects

Bivalent boosters were first recommended for all Americans ages 12 and up in September 2022.

California law limiting medical exemptions from kindergarten vaccines offset by COVID, alternative schooling

The proportion of kindergarteners not up to date with vaccinations rose from 6% in 2019 to 7% in 2020, then fell to 6.01% in 2021.

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems

There were no significant differences in risk among COVID patients with chronic conditions and healthy immune systems or older unvaccinated patients.

Study: 1 in 20 Americans used non-evidence-based COVID treatments

Trust in physicians and science was associated with not using the treatments.

BARDA awards Project Next Gen funding for antibody treatments for COVID, other viruses

The first phase of work focuses on an antibody that broadly protects against circulating SARS-CoV-2 variants.

Sepsis associated with COVID-19 infections more common than thought

Overall, SARS-CoV-2–associated sepsis was present in 28.2% of patients admitted with SARS-CoV-2.